Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8744579

AIDS Res. Hum. Retroviruses 1996 May 20 12 8 683-93

Download in:

View as

Triples

General Info

PMID
8744579